Catestatins also notably

caused degranulation of peripheral blood-derived mast cells (Fig. 1b); however, these cells had a weaker response to wild-type catestatin and its variants when compared with LAD2 cells (5 μm for peripheral blood mast cells versus Fulvestrant concentration 2·5 μm for LAD2 cells), implying different characteristics of these two cell types. The doses of catestatin peptides used in this study were not toxic to mast cells, as evaluated by trypan blue dye exclusion, and lactate dehydrogenase activity (data not shown). When stimulated, mast cells undergo degranulation and release of various eicosanoids in inflammatory or allergic diseases.21 Therefore, given that catestatin peptides induced mast cell degranulation, we investigated their ability to cause the release of LTs and PGs from human mast cells. In support of our hypothesis, wild-type catestatin and its mutants noticeably enhanced LTC4, PGD2 and PGE2 release from LAD2 cells in a dose-dependent manner. Scrambled catestatin had no effect, and compound 48/80 was a positive control (Fig. 1c–e). We also confirmed that wild-type catestatin and its variants significantly augmented LTC4, PGD2 and PGE2 release from peripheral blood-derived mast cells (Fig. 1f–h). Although catestatin peptides increased LTC4 release by

approximately 100-fold, the release of PGD2 and PGE2 was only increased two- to three-fold. We verified that longer stimulation (3–12 hr) of the cells did https://www.selleckchem.com/products/LDE225(NVP-LDE225).html not further increase the amounts of LTC4, PGD2 and PGE2 released (data not shown). As a number of AMPs and neuropeptides known to induce mast cell degranulation have been reported to increase chemokine and cytokine production,16,17 C-X-C chemokine receptor type 7 (CXCR-7) we next tested whether catestatin peptides would also activate mast cells to generate pro-inflammatory cytokines and chemokines, including GM-CSF, IL-4, IL-5, IL-8, TNF-α, MCP-1/CCL2,

MIP-1α/CCL3 and MIP-1β/CCL4. Following 1 hr of stimulation, we observed that wild-type catestatin and its variants noticeably enhanced the mRNA expression levels of the above-mentioned cytokines and chemokines in a dose-dependent manner (Fig. 2). We chose to stimulate the cells for 1 hr because in preliminary experiments the highest mRNA expression levels were observed after 1 hr of a 1–24 hr stimulation. After observing enhanced mRNA expression of various cytokines and chemokines, the stimulatory effects of catestatin peptides on the production of the respective cytokine and chemokine proteins by mast cells were evaluated using an ELISA. Among the cytokines and chemokines tested, wild-type catestatin and its variants, but not scrambled catestatin, only selectively increased the production of GM-CSF, MCP-1/CCL2, MIP-1α/CCL3 and MIP-1β/CCL4 (Fig. 3), and this effect was dose-dependent. The production of cytokines and chemokines was highest after 6 hr of stimulation.